Related Experiment Video

Updated: May 13, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Targeting autophagy to enhance oncolytic virus-based cancer therapy

Songshu Meng1, Jiansheng Xu, Yantao Wu

  • 1Dalian Medical University Cancer Center, Institute of Cancer Stem Cell, 9 Lvshun Road South, Dalian 116044, Chin. ssmeng@yzu.edu.cn

Expert Opinion on Biological Therapy
|March 16, 2013
PubMed
Abstract

Insights

Oncolytic viruses (OVs) interact with cellular autophagy. Modulating autophagy, using inducers or inhibitors, can enhance OV antitumor effects, offering a promising strategy for novel cancer therapies.

Area of Science:

  • Oncology
  • Virology
  • Cell Biology

Background:

  • Autophagy is a fundamental cellular process for maintaining homeostasis.
  • Oncolytic viruses (OVs) disrupt cellular autophagy during infection of tumor cells.
  • Pharmacological modulation of autophagy shows potential in preclinical OV therapy.

Purpose of the Study:

  • To review the interactions between OVs and autophagy.
  • To summarize autophagy's role in OV replication and tumor cell lysis.
  • To explore autophagy modulation as an anticancer strategy.

Main Methods:

  • Literature review of OV-autophagy interactions.
  • Analysis of studies using autophagy inducers (e.g., rapamycin) and inhibitors (e.g., chloroquine).
  • Examination of OV-induced cytotoxicity and oncolysis.

Main Results:

  • Autophagy plays a dual role in OV replication and OV-mediated cell death.
  • Targeting autophagy can significantly enhance OV antitumor efficacy.
  • Understanding the molecular interplay is key for optimizing combination therapies.

Conclusions:

  • Modulating autophagy presents a viable therapeutic strategy to boost OV antitumor effects.
  • Further research into the OV-autophagy molecular mechanisms is warranted.
  • Combination of OVs with autophagy modulators holds significant therapeutic potential.

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...